GLUE-DAC
Live / Applied — Non-final action mailed (as of 23 Mar 2026)
What this means for you
Not registered yet, but its 12 Nov 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99493141
- Mark type
- Stylized text
- Filed
- 12 Nov 2025
- Attorney of record
- Matthew Saunders
Goods and services
- Class 001 — Chemicals: Development of pharmaceutical preparations for the treatment of autoimmune disease and cancer; development of platform technology, namely, immunotherapy platforms for manufacturing autoimmune disease and cancer therapeutics; scientific research services, namely, antibody engineering for analytical and clinical purposes
- Class 042 — Scientific and technological services: Scientific research and development services in the nature of platform technology, namely, development of immunotherapy platforms for the development of autoimmune disease and cancer therapeutics
Owner
- Fortitude Biomedicines, Inc., Waltham, MA, US
Prosecution history
- 23 Mar 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 23 Mar 2026 — NON-FINAL ACTION E-MAILED
- 23 Mar 2026 — NON-FINAL ACTION WRITTEN
- 23 Mar 2026 — ASSIGNED TO EXAMINER
- 17 Mar 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 12 Nov 2025 — APPLICATION FILING RECEIPT MAILED
- 12 Nov 2025 — NEW APPLICATION ENTERED